At the time of writing, Tango Therapeutics Inc [TNGX] stock is trading at $10.33, up 2.99%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TNGX shares have gain 29.45% over the last week, with a monthly amount glided 37.83%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Piper Sandler started tracking the stock with Overweight rating on August 19, 2025, and set its price target to $11. On July 17, 2024, Jefferies initiated with a Buy rating and assigned a price target of $19 on the stock. Cantor Fitzgerald started tracking the stock assigning an Overweight rating. Piper Sandler initiated its recommendation with an Overweight and recommended $18 as its price target on February 12, 2024. B. Riley Securities started tracking with a Buy rating for this stock on December 08, 2023, and assigned it a price target of $16. In a note dated October 20, 2022, H.C. Wainwright upgraded a Buy rating on this stock but restated the target price of $10.
For the past year, the stock price of Tango Therapeutics Inc fluctuated between $1.03 and $10.07. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. Tango Therapeutics Inc [NASDAQ: TNGX] shares were valued at $10.33 at the most recent close of the market. An investor can expect a potential return of 16.17% based on the average TNGX price forecast.
Analyzing the TNGX fundamentals
According to Tango Therapeutics Inc [NASDAQ:TNGX], the company’s sales were 66.50M for trailing twelve months, which represents an 363.61% jump. Gross Profit Margin for this corporation currently stands at 0.97% with Operating Profit Margin at -6.47%, Pretax Profit Margin comes in at -5.98%, and Net Profit Margin reading is -5.99%. To continue investigating profitability, this company’s Return on Assets is posted at -0.61, Equity is -0.8 and Total Capital is -0.79. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.92 points at the first support level, and at 9.51 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.97, and for the 2nd resistance point, it is at 11.61.
Ratios To Look Out For
It is important to note that Tango Therapeutics Inc [NASDAQ:TNGX] has a current ratio of 8.88. Further, the Quick Ratio stands at 8.88, while the Cash Ratio is 0.99. Considering the valuation of this stock, the price to sales ratio is 20.91, the price to book ratio is 7.20.
Transactions by insiders
Recent insider trading involved Third Rock Ventures IV, L.P., 10% Owner, that happened on Oct 23 ’25 when 0.48 million shares were sold. 10% Owner, Third Rock Ventures IV, L.P. completed a deal on Oct 23 ’25 to buy 0.48 million shares. Meanwhile, 10% Owner Third Rock Ventures IV, L.P. sold 0.5 million shares on Sep 25 ’25.
